Skip to main content

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Introduction

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the fifth settlement in the City’s six-year legal battle against opioid distributors and manufacturers.

The full terms of the settlement will be disclosed on October 3, 2024.

This agreement follows previous settlements with Allergan and CVS for $45 million each, Teva for $80 million, and Cardinal Health for $152.5 million, bringing the City’s total opioid-related recoveries to $402.5 million. The remaining cases against Johnson & Johnson, McKesson, and AmerisourceBergen are set to go to trial next week.

City Solicitor explained that Walgreens requested a 30-day delay in announcing the settlement details, which the City agreed to in order to focus on the upcoming trial against other key defendants in the opioid epidemic.

Medical Record Review Free Trial For Mass Tort AttorneysBaltimore's mayor praised the legal efforts, emphasizing the need for substantial resources to combat the opioid crisis. The funds from these settlements will help bolster ongoing initiatives aimed at addressing the epidemic and providing support where it's most needed.

The outside legal team working with the City also expressed pride in the progress made and readiness for the upcoming trial.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!